Strs Ohio Concert Pharmaceuticals, Inc. Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 23, 2019	SELL	$11.25 - $16.17 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$12.82 - $17.88 $362,806 - $506,004	-28,300 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$16.83 - $21.66 $55,538 - $71,478	-3,300 Reduced 10.44%	28,300 $476,000
Q1 2018 Apr 20, 2018	BUY	$19.24 - $28.03 $69,264 - $100,908	3,600 Added 12.86%	31,600 $723,000
Q4 2017 Jan 23, 2018	BUY	$13.96 - $29.05 $390,880 - $813,400	28,000	28,000 $724,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.